Clinical trial
Safety and Efficacy of Lubiprostone in Pediatric Patients With Constipation
NCT00452335 · Sucampo Pharma Americas, LLC, Industry · Completed
Key facts
| NCT number | NCT00452335 |
|---|---|
| Title | Safety and Efficacy of Lubiprostone in Pediatric Patients With Constipation |
| Official title | A Multi-center, Open-labeled Study of the Safety, Efficacy, and Pharmacokinetics of Lubiprostone in Pediatric Patients With Constipation |
| Lead sponsor | Sucampo Pharma Americas, LLC, Industry |
| Collaborators | Sucampo Pharmaceuticals, Inc. Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Constipation |
| Intervention type | Drug |
| Interventions | Lubiprostone |
| Enrollment | 127 |
| Start date | Jan 1, 2007 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Mar 27, 2007 |
| Last update posted | Dec 17, 2019 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: